Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 320

1.

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.

Poulsom H, Charles PJ.

Clin Rev Allergy Immunol. 2008 Feb;34(1):4-10. doi: 10.1007/s12016-007-8016-3.

PMID:
18270850
[PubMed - indexed for MEDLINE]
2.

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.

Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.

J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.

PMID:
17611988
[PubMed - indexed for MEDLINE]
3.

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.

Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.

Arthritis Rheum. 2008 Jan;58(1):36-45. doi: 10.1002/art.23188.

PMID:
18163519
[PubMed - indexed for MEDLINE]
Free Article
4.

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.

Liu X, Jia R, Zhao J, Li Z.

J Rheumatol. 2009 Jun;36(6):1136-42. doi: 10.3899/jrheum.080796. Epub 2009 May 15.

PMID:
19447936
[PubMed - indexed for MEDLINE]
5.

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.

Wagner E, Skoumal M, Bayer PM, Klaushofer K.

Rheumatol Int. 2009 Sep;29(11):1315-21. doi: 10.1007/s00296-009-0854-2. Epub 2009 Jan 28.

PMID:
19184032
[PubMed - indexed for MEDLINE]
6.

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.

Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.

Arthritis Res Ther. 2006;8(4):R119.

PMID:
16859519
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.

Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U, Sengül A.

Protein Pept Lett. 2008;15(3):314-7.

PMID:
18336364
[PubMed - indexed for MEDLINE]
8.

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.

Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR.

Arthritis Rheum. 2007 Aug;56(8):2503-11.

PMID:
17665451
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.

Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieudé P, Meyer O, Chollet Martin S.

Arthritis Res Ther. 2008;10(6):R142. doi: 10.1186/ar2570. Epub 2008 Dec 10.

PMID:
19077182
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.

Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators.

Autoimmun Rev. 2012 Sep;11(11):815-20. doi: 10.1016/j.autrev.2012.02.015. Epub 2012 Feb 27.

PMID:
22394488
[PubMed - indexed for MEDLINE]
12.

Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?

Szekanecz Z, Soós L, Szabó Z, Fekete A, Kapitány A, Végvári A, Sipka S, Szücs G, Szántó S, Lakos G.

Clin Rev Allergy Immunol. 2008 Feb;34(1):26-31. doi: 10.1007/s12016-007-8022-5. Review.

PMID:
18270854
[PubMed - indexed for MEDLINE]
13.

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.

Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.

Arthritis Rheum. 2010 Jan;62(1):44-52. doi: 10.1002/art.25036.

PMID:
20039432
[PubMed - indexed for MEDLINE]
Free Article
14.

A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.

Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.

J Rheumatol. 2011 Jul;38(7):1265-72. doi: 10.3899/jrheum.101086. Epub 2011 Apr 1.

PMID:
21459947
[PubMed - indexed for MEDLINE]
15.

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.

Coenen D, Verschueren P, Westhovens R, Bossuyt X.

Clin Chem. 2007 Mar;53(3):498-504. Epub 2007 Jan 26.

PMID:
17259232
[PubMed - indexed for MEDLINE]
Free Article
16.

Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.

Sghiri R, Bouajina E, Bargaoui D, Harzallah L, Fredj HB, Sammoud S, Ghedira I.

Rheumatol Int. 2008 Nov;29(1):59-62. doi: 10.1007/s00296-008-0614-8. Epub 2008 May 22.

PMID:
18496693
[PubMed - indexed for MEDLINE]
17.

The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.

Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G, Mueller-Hilke B.

J Rheumatol. 2009 Dec;36(12):2670-4. doi: 10.3899/jrheum.081263. Epub 2009 Nov 2.

PMID:
19884278
[PubMed - indexed for MEDLINE]
18.

Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.

Damjanovska L, Thabet MM, Levarth EW, Stoeken-Rijsbergen G, van der Voort EI, Toes RE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2010 Apr;69(4):730-2. doi: 10.1136/ard.2009.108456. Epub 2009 May 17.

PMID:
19451136
[PubMed - indexed for MEDLINE]
19.

Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.

Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI.

J Rheumatol. 2009 Mar;36(3):491-500. doi: 10.3899/jrheum.080656. Epub 2009 Feb 17.

PMID:
19228660
[PubMed - indexed for MEDLINE]
20.

Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review.

Luime JJ, Colin EM, Hazes JM, Lubberts E.

Ann Rheum Dis. 2010 Feb;69(2):337-44. doi: 10.1136/ard.2008.103283. Epub 2009 Mar 15. Review.

PMID:
19289382
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk